Anti-allergic composition as well as face cream and preparation method thereof

A technology of composition and anti-allergic cream, which is applied in the field of anti-allergic composition and anti-allergic cream, can solve the problems that the skin barrier function cannot be effectively repaired, the sensitive skin has no effective soothing effect, and the inflammatory response cannot be effectively inhibited, so as to relieve skin irritation. Effects of tingling sensation, repair of horny barrier function, and enhancement of tolerance threshold

Pending Publication Date: 2021-03-30
广州市中通生化制品有限公司
View PDF10 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The idea of ​​traditional anti-allergic products is generally to make the formula as simple and gentle as possible, or to add anti-allergic active ingredients in the concept, or to add active ingredients to restore the horny barrier function. Reactive sensitive skin has no effective soothing effect; the concept of adding anti-allergic active ingredients can not effectively inhibit the inflammatory response; adding active ingredients to restore the horny barrier function alone cannot inhibit the inflammatory response, and the inflammatory response cannot be controlled. The skin barrier function cannot be effectively repair

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-allergic composition as well as face cream and preparation method thereof
  • Anti-allergic composition as well as face cream and preparation method thereof
  • Anti-allergic composition as well as face cream and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] An anti-allergic composition provided by the present invention comprises the following components in parts by weight: 0.5 g of cactus stem extract, 0.07 g of root extract of Astragalus membranaceus, 0.05 g of root extract, and calendula flower extract 0.04g, Albizia Julibrissin Extract 0.02g, Gastrodia elata Root Extract 0.02g, Ceramide 3 0.1g, Gentiana Extract 0.1g, Centella Asiatica Extract 0.2g, 1,2-pentanediol (and) 4- 0.15 g of tert-butylcyclohexanol.

[0038] The cream component containing the anti-allergic composition in embodiment 1 is:

[0039] Phase A: water balance, glycerin 10%, propylene glycol 8%, glycerol-26 2%, p-hydroxyacetophenone 0.5%, magnesium sulfate 0.5%;

[0040] Phase B: Cyclopentasiloxane (and) Cyclohexasiloxane 10%, Dimethicone 3%, Isooctyl Palmitate 3%, Methylsilsesquioxane 0.5 %, Zinc Oxide (and) Triethoxycaprylylsilane 0.1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 1% , Cyclopentasiloxane (and) Distearyldimonium Hecto...

Embodiment 2

[0044] An anti-allergic composition provided by the present invention comprises the following components in parts by weight: 1.2 g of cactus stem extract, 0.15 g of Astragalus membranaceus root extract, 0.04 g of Albizia Julibrissin flower extract, and 0.03 g of Gastrodia elata root extract g, ceramide 3 1g, gentian extract 0.3g, centella asiatica extract 0.3g, 1,2-pentanediol (and) 4-tert-butylcyclohexanol 0.1g.

[0045] The cream component containing the anti-allergic composition in embodiment 2 is:

[0046] Phase A: water balance, glycerin 10%, propylene glycol 8%, glycerol polyether-262%, p-hydroxyacetophenone 0.5%, magnesium sulfate 0.5%;

[0047] Phase B: Cyclopentasiloxane (and) Cyclohexasiloxane 10%, Dimethicone 3%, Isooctyl Palmitate 3%, Methylsilsesquioxane 0.5 %, Zinc Oxide (and) Triethoxycaprylylsilane 0.1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 1% , Cyclopentasiloxane (and) Distearyldimonium Hectorite (and) Propylene Carbonate 2%, Cetyl PE...

Embodiment 3

[0051] An anti-allergic composition provided by the present invention comprises the following components in parts by weight: 0.8 g of cactus stem extract, 0.1 g of Astragalus membranaceus root extract, 0.05 g of Albizia Julibrissin flower extract, and 0.04 g of Gastrodia elata root extract g, ceramide 3 0.4g, gentian extract 0.2g, centella asiatica extract 0.3g, 1,2-pentanediol (and) 4-tert-butylcyclohexanol 0.5g.

[0052] The cream component containing the anti-allergic composition in embodiment 3 is:

[0053] Phase A: water balance, glycerin 10%, propylene glycol 8%, glycerol polyether-262%, p-hydroxyacetophenone 0.5%, magnesium sulfate 0.5%;

[0054] Phase B: Cyclopentasiloxane (and) Cyclohexasiloxane 10%, Dimethicone 3%, Isooctyl Palmitate 3%, Methylsilsesquioxane 0.5 %, Zinc Oxide (and) Triethoxycaprylylsilane 0.1%, Dimethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer 1% , Cyclopentasiloxane (and) Distearyldimonium Hectorite (and) Propylene Carbonate 2%, Cetyl P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an anti-allergy composition as well as face cream and a preparation method thereof, and aims to provide the face cream which can inhibit inflammatory reaction, repair cutin barrier function and gradually enhance skin tolerance. According to the technical method, the composition comprises the following components: 0.5-2 part of opuntia streptacantha stem extract, 0.07-0.36 part of astragalus membranaceus root extract, 0.02-0.09 part of albizia flower extract, 0.02-0.09 part of gastrodia elata root extract, 0.1-2 part of ceramide 3, 0.03-0.6 part of 4-tert-butyl cyclohexanol, 0.05-0.5% of gentian extract and 0.05-0.5 part of centella extract. The invention belongs to the technical field of cosmetics.

Description

technical field [0001] The invention discloses an anti-allergic composition, specifically an anti-allergic face cream, and also discloses a preparation method of the face cream, which belongs to the technical field of cosmetics. Background technique [0002] Sensitive skin (SensitiveSkin, SS) specifically refers to a hyperreactive state of the skin under physiological or pathological conditions, mainly occurs on the face, and is clinically manifested as burning, tingling, Subjective symptoms such as itching and tightness, with or without objective signs such as erythema, scaling, and telangiectasia. [0003] The reason for the formation of sensitive skin is the interaction between the internal factors of the skin and external factors, which causes the damage of the skin barrier function. When the skin is stimulated, the skin becomes inflamed, the input of sensory nerve signals increases, and the immune response increases, leading to the development of sensitive skin and sens...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K8/9789A61K8/9794A61K8/68A61Q19/00A61P17/00A61K36/8988A61P37/08
CPCA61K8/9789A61K8/9794A61K8/68A61Q19/005A61P17/00A61K36/481A61K36/515A61K36/48A61K36/8988A61K36/238A61K36/28A61P37/08A61K2800/5922A61K2300/00
Inventor 王之宁朱洪杨霞卿唐芳勇
Owner 广州市中通生化制品有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap